hCG Tumor Marker

Also Known As

Quantitative hCG

Beta hCG

Total hCG

Total beta hCG

Intact hCG

Formal Name

Human Chorionic Gonadotropin, quantitative

This article was last reviewed on

September 13, 2018.

This article waslast modified on April 1, 2020.

At a Glance

Why Get Tested?

To help diagnose and monitor gestational trophoblastic disease or germ cell tumors

When To Get Tested?

When your symptoms suggest gestational trophoblastic disease or germ cell tumors; to evaluate the effectiveness of treatment for these conditions; to monitor for recurrence

Sample Required?

A blood sample drawn from a vein

Test Preparation Needed?

None

You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

What is being tested?

Human chorionic gonadotropin (hCG) is a hormone, made up of an alpha and beta subunit, that is produced by the placenta and normally is only measurable during pregnancy. Some abnormal tissues, tumors, and cancers, however, may also produce hCG, making the hCG test useful as a tumor marker. This test measures the amount of intact hCG, and sometimes the beta subunit of hCG, in the blood.

An increased level of hCG is seen with gestational trophoblastic disease and some germ cell tumors (benign and cancerous). If hCG is increased with these conditions, then the hCG test can be used as a diagnostic and monitoring tool.

Gestational trophoblastic disease (GTD) is a group of tumor types that develop in a woman's uterus from the layer of cells surrounding an embryo that creates the placenta during a normal pregnancy (trophoblasts) and produces hCG. GTD usually occurs at the beginning of pregnancy after an egg has been fertilized, but instead of supporting the growth of a fetus, the cells form abnormal tissue masses. In most cases, the tumors are benign, but in a small percentage of people, they are cancerous. According to the American Cancer Society, GTD occurs in about 1 in 1,000 pregnancies. It can also occur after a normal pregnancy or after a miscarriage or abortion. The primary forms of GTD are:

Hydatidiform mole – also called a "molar pregnancy," which may be complete (only tumor tissue) or a mixture of tumor and fetal tissue but does not develop into a viable baby; these are usually benign but must be surgically removed.
Invasive mole – a hydatidiform mole that grows into the uterus wall; it must be surgically removed; however, the condition can persist if GTD tissue remains.
Choriocarcinoma – a rare cancer that may develop from the GTD tumor tissue in about 2 to 7 per 100,000 pregnancies; these cancers can grow quickly and spread to other parts of the body.
Placental site trophoblastic tumor – also rare, this tumor arises at the site of placental attachment in the uterus. This tumor usually develops after a normal or aborted pregnancy but doesn't often spread through the body.
Epithelioid trophoblastic tumor – extremely rare, this tumor is similar in nature to the choriocarcinoma but is now considered a separate disease. It may take many years after a pregnancy for this tumor to be detected and may have already spread to other parts of the body.

Note: With appropriate treatment, the cure rate for most GTD is very high. For more on this, see the links in the Related Content section below.

Germ cell tumors and cancers occur primarily in the ovaries and testicles but can also rarely develop in other locations such as the chest.

Germ cell tumors can occur in the egg-producing cells of the ovaries and are more often seen in younger women (for more, see Ovarian Cancer).
Germ cell tumors can affect cells within the testicles that make sperm and account for more than 90% of testicular cancers (for more, see Testicular Cancer).

Levels of hCG may also be elevated in other diseases such as liver, breast, lung, skin, and stomach cancers. Increased levels may also be seen in non-cancer conditions such as cirrhosis, duodenal ulcer, and inflammatory bowel disease.

Common Questions

How is it used?

Quantitative human chorionic gonadotropin (hCG) testing, often called beta hCG (βhCG), measures the amount of hCG present in the blood. It may be used to help diagnose gestational trophoblastic disease (GTD) or, with other tests such as AFP and lactate dehydrogenase, to help diagnose germ cell tumors.

Since hCG is not normally present in men or non-pregnant women, it is useful as a tumor marker. If the tumor or cancer is producing hCG, then the hCG test can be used to help detect and monitor tumor activity.

When testing hCG as a tumor marker, unlike detecting pregnancy, it is important to measure the intact (alpha + beta subunits) form of hCG. There may be some benefit to also measuring the beta-subunit of hCG in certain tumors, and different labs will detect intact and βhCG differently. For this reason, it is very important to continue to use the same lab when monitoring GTD or germ cell tumors.
When is it ordered?
A quantitative hCG test may be ordered when a healthcare practitioner suspects that a person may have gestational trophoblastic disease (GTD) or a germ cell tumor due to the person's clinical presentation, signs and symptoms.

In women, signs and symptoms of GTD may include:

Vaginal bleeding during pregnancy

Fatigue related to anemia (if blood loss is significant)

Abdominal swelling that may happen more rapidly than with a normal pregnancy

Pre-eclampsia early in the pregnancy

Nausea, vomiting that may be more severe than with a normal pregnancy

A positive pregnancy test (qualitative hCG) but no fetus is seen on ultrasound

A uterus that remains enlarged after a pregnancy

Signs and symptoms of a germ cell tumor in women and men are similar to those of ovarian cancer and testicular cancer, respectively.

If a person is diagnosed with one of these conditions and the hCG is initially elevated, then the test will be ordered at intervals to monitor the effectiveness of treatment and to detect tumor recurrence.
What does the test result mean?

In men and in non-pregnant women, the hCG level is normally undetectable.

When the test is used as a tumor marker, an elevated hCG level may mean that an individual has a germ cell tumor or gestational trophoblastic disease (GTD).

A high level of hCG occurs in both GTD and normal pregnancy. However, hCG rises at a constant and predictable rate, doubling approximately every 36-48 hours in early normal pregnancy. Levels of hCG in GTD show altered rates of production and, paired with imaging such as ultrasound, can identify abnormalities in the pregnancy requiring intervention. Alternatively, the hCG levels may be much higher than expected in normal pregnancy or not show the expected decrease after pregnancy or abortion/miscarriage.

During treatment for GTD or a germ cell tumor, a falling hCG level generally indicates that the condition is responding to treatment (approximately 50% decrease expected every 1.5 days), while persistent or rising levels may indicate that it is not responding to therapy. An increased hCG level after treatment may indicate a recurrence of disease.
Is there anything else I should know?

False-positive serum hCG results may occur due to the presence of certain drugs such as anticonvulsants, antiparkinsonian agents, hypnotics, and tranquilizers that may interfere with the test. In addition, certain types of antibodies that may be present in some individuals and fragments of the hCG molecule, if present, can also interfere with test results. Generally, if results are questionable, they may be confirmed by testing with a different method.

Rarely, an hCG test may be ordered to help diagnose and monitor tumors and cancers other than GTD or germ cell tumors.
Can urine be tested instead of blood?

If hCG is elevated in the blood, then it will be elevated in the urine, but the results are not interchangeable. Blood is the preferred sample for tumor testing.
Can gestational trophoblastic disease (GTD) be prevented?

No. Other than to avoid becoming pregnant, GTD is not preventable since GTD is associated with pregnancy. However, since it is rare, most women will never have the condition. Since GTD can be detected soon after conception in most cases and successfully treated, it is rarely considered a significant cause to avoid pregnancy.
Can I have a normal pregnancy after having GTD?

Yes, in most cases, although you will be at a higher risk of having GTD again. After treatment for GTD, you will need to wait for a period of time as advised by your healthcare provider before becoming pregnant again.
I heard that some athletes may be tested for hCG. Why is that?

Some athletes, including professional and international athletes, must submit to tests that detect steroids and other performance-enhancing substances. These athletes are often tested throughout their careers to ensure that no 'doping' occurs. Urine tests can detect about 200 compounds, including steroids and other anabolic substances, erythropoietin, and substances that cause false-negative results (masking agents) to hide illicit substance use. Sports organizations specify which compounds they might be looking for by doing a complete screen.

Some athletes who use steroids take beta-hCG to reverse shrinking of their testicles, which can be a side effect of steroids. Thus, some athletes may be tested for hCG to help identify steroid use. (For more on this, see the article on Drug Abuse Testing.)

See More Common Questions See Less Common Questions

View Sources

Sources Used in Current Review

2018 review performed by Kristin Hauff, PhD, FCACB, Interior Health Laboratories BC.

Sisinni L., Landriscina M. (2015) The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects. In: Scatena R. (eds) Advances in Cancer Biomarkers. Advances in Experimental Medicine and Biology, vol 867. Springer, Dordrecht.

Nwabuobi C, et al. (2017) hCG: Biological Functions and Clinical Applications. International Journal of Molecular Science. 18(10) pii: E2037. Available online at https://www.mdpi.com/1422-0067/18/10/2037/htm. Accessed October 2018.

Stenman U., Alfthan H. (2013) Determination of human chorionic gonadotropin. Best Practice & Research Clinical Endocrinology & Metabolism. 27(6); 783-793.

Sokoll L.J., Rai A.J., and Chan D.W. (2012) Tumor Markers. In: Burtis C.A, Ashwood E.R and Burns D.E. (eds) Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 5th edition Elsevier, St. Louis, Missouri.

Braustein GD, Buster JE, Soares JR and Gross SJ (1983). Pregnancy hormone concentrations in marijuana users. Life Science 33(2): 195-9.

Braustein GD, Thompson R, Gross SJ and Soares JR (1983). Marijuana use does not spuriously elevate serum human chorionic gonatotropin levels. Urology 25(6): 605-6.

Montagnana M., et al. (2011) Human chorionic gonadotropin in pregnancy diagnostics. Clinica Chimica Acta 412(17): 1515-1520. Available online at http://www.bccancer.bc.ca/health-professionals/clinical-resources/cancer-management-guidelines/gynecology/gestational-trophoblastic-neoplasia#Diagnosis-Gestational-Trophoblastic-Neoplasia. Accessed October 2018.

Sources Used in Previous Reviews

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

(2004). Germ Cell Tumors: Beta-Human Chorionic Gonadotropin. Specialty Laboratories, Use and Interpretation of Laboratory Tests, Books [On-line information]. Available online at http://oncology.specialtylabs.com/books/display.asp?id=544.

American Cancer Society. What is gestational trophoblastic disease? Available online at http://www.cancer.org/Cancer/GestationalTrophoblasticDisease/DetailedGuide/gestational-trophoblastic-disease-what-is-g-t-d. Accessed March 2011.

MedlinePlus Medical Encyclopedia. Gestational Trophoblastic Disease. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/007333.htm. Accessed March 2011.

Enrique Hernandez, MD, FACOG, FACS. Gestational Trophoblastic Neoplasia. Available online at http://emedicine.medscape.com/article/279116-overview. Accessed March 2011.

Farinde, A. (Updated 2014 July 2). Human Chorionic Gonadotropin (hCG). Medscape Drugs & Diseases [On-line information]. Available online at http://emedicine.medscape.com/article/2089158-overview. Accessed September 2014.

(Revised 2014 March 3). Gestational Trophoblastic Disease. American Cancer Society [On-line information]. Available online at http://www.cancer.org/acs/groups/cid/documents/webcontent/003104-pdf.pdf. Accessed September 2014.

(Revised 2013 October 30). Tumor Markers. American Cancer Society [On-line information]. Available online at http://www.cancer.org/acs/groups/cid/documents/webcontent/003189-pdf.pdf. Accessed September 2014.

(Modified 2014 April 25). General Information About Gestational Trophoblastic Disease. National Cancer Institute [On-line information]. Available online at http://www.cancer.gov/cancertopics/pdq/treatment/gestationaltrophoblastic/HealthProfessional. Accessed September 2014.

(Modified 2014 July 11). General Information About Testicular Cancer. National Cancer Institute [On-line information]. Available online at http://www.cancer.gov/cancertopics/pdq/treatment/testicular/HealthProfessional. Accessed September 2014.

Zhang, Y. (2013 March 13). Tumor Markers: Alpha-fetoprotein (AFP) and human Chorionic Gonadotropin (hCG). Clinical Chemistry Trainee Council Pearls of Laboratory Medicine [On-line information]. Available online through http://www.aacc.org. Accessed September 2014.

Hussain, F. et. al. (Updated 2012 August 1). Gynecologic Tumor Markers Tumor Marker Overview. Medscape Drugs & Diseases http://emedicine.medscape.com/article/269839-overview. Accessed September 2014.

Storck, S. (Updated 2012 November 8). Hydatidiform mole. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000909.htm. Accessed September 2014.

Sturgeon C, et. al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 2008; 54(12):e11-79. Available online through http://www.aacc.org. Accessed October 2014.

United States Anti-Doping Agency. Effects of Performance Enhancing Drugs. Available online at http://www.usada.org/substances/effects-of-performance-enhancing-drugs/. Accessed October 2014.

Quest Diagnostics. Bet-HCG, serum quant tumor marker. Available online at http://www.questdiagnostics.com/testcenter/BUOrderInfo.action?tc=20862&labCode=QER. Accessed October 2014.

Medscape. Beta human chorionic gonadotropin. Available online at http://emedicine.medscape.com/article/269839-overview#aw2aab6b4. Accessed October 2014.

Ask a Laboratory Scientist

This form enables patients to ask specific questions about lab tests. Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, American Society for Clinical Laboratory Science. Please allow 2-3 business days for an email response from one of the volunteers on the Consumer Information Response Team.

Please indicate whether you are a

Country

I have read and agree to the Privacy Policy (read the Privacy Policy)

I have read and agree to the Terms of Use (read the Terms of Use)

I agree to the disclaimer (read the disclaimer).

Disclaimer

Thank you for using the Consumer Information Response Service ("the Service") to inquire about the meaning of your lab test results. The Service is provided free of charge by the American Society for Clinical Laboratory Science, which is one of many laboratory organizations that supports Lab Tests Online.
Please note that information provided through this free Service is not intended to be medical advice and should not be relied on as such. Although the laboratory provides the largest single source of objective, scientific data on patient status, it is only one part of a complex biological picture of health or disease. As professional clinical laboratory scientists, our goal is to assist you in understanding the purpose of laboratory tests and the general meaning of your laboratory results. It is important that you communicate with your physician so that together you can integrate the pertinent information, such as age, ethnicity, health history, signs and symptoms, laboratory and other procedures (radiology, endoscopy, etc.), to determine your health status. The information provided through this Service is not intended to substitute for such consultations with your physician nor specific medical advice to your health condition.
By submitting your question to this Service, you agree to waive, release, and hold harmless the American Society for Clinical Laboratory Science and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "ASCLS") and the American Association for Clinical Chemistry and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "AACC") from any legal claims, rights, or causes of action you may have in connection with the responses provided to the questions that you submit to the Service.
AACC, ASCLS and its Service volunteers disclaim any liability arising out of your use of this Service or for any adverse outcome from your use of the information provided by this Service for any reason, including but not limited to any misunderstanding or misinterpretation of the information provided through this Service.

See Full Form See Less

On This Site

Elsewhere On The Web

Ask a Laboratory Scientist